Brain Fog, Word-Finding, and the Fear of Dementia: What's Actually Going On in Perimenopause
Losing words mid-sentence. Walking into a room and forgetting why you went there. Rereading the same paragraph five times. And beneath all of it: the fear that this is the beginning of something irreversible. The research has answers and most of them are more reassuring than the fear suggests.
By Dr. Julie Rashkis, Psy.D. | Licensed Psychologist | Menopause Society Certified Practitioner | therapyformidlife.com
'I'm in the middle of a sentence and the word just disappears. I know exactly what I mean. The word was there a moment ago. And then it's just gone, and I'm standing there in a meeting staring at people, and I think: is this what it starts with?' She pauses. 'My mother had Alzheimer's. I'm terrified.'
This fear is one of the most emotionally loaded experiences of perimenopause and one of the least well-contextualized. Word-finding difficulty, memory lapses, difficulty concentrating, and mental fog are among the most commonly reported cognitive symptoms of the perimenopause transition, affecting approximately half of all women going through it. But for women with a family history of dementia, or for high-functioning women who have built their professional and personal identities around cognitive sharpness, these symptoms carry a weight that goes far beyond inconvenience.
The research on perimenopause and cognition has important things to say; both about what is actually happening in the brain during the transition, and about the relationship (and the crucial differences) between perimenopausal brain fog and Alzheimer's disease. Understanding both can be the difference between years of unnecessary fear and a clear-eyed path toward support.
What the Brain Is Actually Doing During Perimenopause
Estrogen is not simply a reproductive hormone; it is a neuroactive steroid with significant roles in brain structure and function. Estrogen receptors are densely expressed in the hippocampus and prefrontal cortex, the two brain regions most critical for episodic memory (remembering events and experiences), working memory (holding information in mind while using it), verbal memory, and processing speed. When estrogen fluctuates erratically during perimenopause, these receptor-rich regions experience functional disruption.
Estrogen's roles in the brain are specific and measurable. It upregulates brain-derived neurotrophic factor (BDNF), which supports neuronal survival, synaptic plasticity, and the formation of new neural connections. It promotes acetylcholine synthesis in the basal forebrain, a region that degrades early in Alzheimer's disease. It regulates the brain's glucose metabolism: research has documented that across the menopause transition, the brain's ability to use glucose as fuel can decrease by roughly 15 to 25%, producing what researchers describe as a state of neural energy deficit. At a cellular level, this energy gap is part of what women experience as that distinctive 'running on low battery' feeling; the sense that cognitive effort costs more than it used to.
The SWAN study — Study of Women's Health Across the Nation — one of the most methodologically rigorous longitudinal studies of the menopause transition, documented that women performed worse on verbal memory and processing speed tests during perimenopause compared to both their pre-perimenopause baseline and their postmenopausal follow-up. This finding is critical: the perimenopause transition itself appears to be the most cognitively disruptive phase, and for most women, cognitive function partially recovers as hormones stabilize in postmenopause.
The cognitive disruption of perimenopause is compounded by two major indirect contributors: sleep deprivation and mood changes. Hot flashes fragment sleep architecture, reducing the deep and REM sleep phases during which memory consolidation and neural detoxification occur. Progesterone's decline removes its GABAergic calming effect, further disrupting sleep. And anxiety and depression, both more prevalent during perimenopause, independently impair attention, concentration, and working memory. The cognitive symptoms of perimenopause are rarely driven by a single mechanism; they reflect the intersection of direct hormonal effects, sleep deprivation, and mood disruption operating simultaneously.
"The SWAN study found that verbal memory and processing speed declined during perimenopause compared to both the premenopausal baseline and postmenopausal follow-up: meaning the transition itself is the peak of cognitive disruption, and most women recover after hormones stabilize." — Joffe et al., SWAN
Brain Fog vs. Dementia: The Differences That Matter
The fear that perimenopause brain fog is early Alzheimer's is one of the most common and most distressing beliefs women bring to clinical settings. It is also, for most women, not supported by the evidence. The differences between perimenopausal cognitive changes and dementia are clinically meaningful.
Feature: Age of onset
Perimenopause brain fog: Typically 40s to early 50s, coinciding with the hormonal transition
Alzheimer's disease / dementia: Rare before 65; early-onset AD accounts for fewer than 5% of all cases
Feature: Pattern
Perimenopause brain fog: Fluctuates with hormonal shifts, sleep quality, and stress — 'good days and bad days'
Alzheimer's disease / dementia: Progressive and worsening over time; does not fluctuate or improve
Feature: Word-finding
Perimenopause brain fog: Tip-of-tongue experiences; word retrieval lapses; the word comes back later
Alzheimer's disease / dementia: Words not retrieved at all; language comprehension also affected as disease progresses
Feature: Navigation
Perimenopause brain fog: Occasional forgetting of why you walked into a room; quickly reoriented
Alzheimer's disease / dementia: Getting lost in familiar places; inability to follow familiar routes
Feature: Functional impact
Perimenopause brain fog: Frustrating; affects efficiency and confidence; tasks still completed
Alzheimer's disease / dementia: Progressive inability to manage finances, medication, complex tasks, eventually basic self-care
Feature: Insight
Perimenopause brain fog: Strong — women are very aware of and distressed by their cognitive changes
Alzheimer's disease / dementia: Insight typically diminishes as disease progresses; anosognosia common
Feature: Resolution
Perimenopause brain fog: Often improves as hormones stabilize postmenopausally; responds to sleep, stress, hormonal treatment
Alzheimer's disease / dementia: Irreversible and progressive regardless of intervention
UT Physicians gynecologist and Menopause Society Certified Practitioner Dr. Ana Mosquera notes that dementia before the early-to-mid 50s is extremely rare. Unless there is a significant family history of early-onset Alzheimer's or other dementia under age 60, the word-finding difficulties and memory lapses of perimenopause are almost certainly not its beginning. The strong insight women typically have into their cognitive changes — the distress, the frustration, the awareness that something is different — is itself a meaningful clinical signal. Anosognosia, the lack of awareness of one's own cognitive impairment, becomes common as Alzheimer's progresses. The woman who is terrified by her word-finding lapses is almost certainly not experiencing early dementia.
The Dementia Question: What the Research Actually Shows
The relationship between estrogen, the menopause transition, and long-term Alzheimer's risk is an area of active and evolving research — and it is worth being precise about what is known, what is emerging, and what is not yet established.
Women have higher rates of Alzheimer's disease than men, even after accounting for the fact that women live longer on average. This sex difference has prompted significant research interest in whether the hormonal changes of menopause contribute to this disparity. Estrogen has documented neuroprotective properties — it promotes amyloid clearance, supports the cholinergic system, and reduces neuroinflammation — and its loss at menopause may plausibly affect long-term Alzheimer's risk.
Research has found that surgical menopause (bilateral oophorectomy) before natural menopause, which produces an abrupt estrogen loss rather than a gradual transition, is associated with higher rates of cognitive impairment over time than natural menopause in age-matched women. An earlier age at natural menopause has similarly been associated with increased dementia risk in some population-based studies. These findings are consistent with the hypothesis that prolonged estrogen exposure across the reproductive lifespan is protective for cognitive aging.
The 'critical window hypothesis' — supported by data from the KEEPS (Kronos Early Estrogen Prevention Study) — proposes that hormone therapy initiated during perimenopause or early postmenopause may have neuroprotective effects that are not available when initiated much later. KEEPS enrolled women within three years of menopause and found improved verbal memory and mood with estradiol therapy. In contrast, the earlier WHIMS (Women's Health Initiative Memory Study), which enrolled women aged 65 to 79 — well past any critical window — found no cognitive benefit and showed increased dementia risk. The design differences between these studies explain much of the apparent contradiction in the literature.
What is not established: that perimenopausal brain fog is a direct path to dementia. The cognitive changes of perimenopause are primarily driven by hormonal volatility, sleep disruption, and mood — not neurodegeneration. About 11 to 13% of women show clinically significant cognitive impairment during perimenopause, and for most, cognitive function improves after hormones stabilize. The brain fog of perimenopause is not a verdict on future cognitive health. For women with significant family history of early-onset Alzheimer's, a neurological consultation to establish a cognitive baseline is reasonable — and that conversation should happen with a neurologist, not be self-managed through fear.
"Cognitive symptoms at perimenopause should not be confused with dementia, which is rare before age 64. Only about11-13% of women show clinically significant cognitive impairment during the transition — and findings suggest that most cognitive changes are limited to the perimenopausal period itself."
— Brain Fog in Menopause, Menopause (2022)
What's Driving Your Fog: The Treatable Contributors
Because perimenopause brain fog is multifactorial, identifying its primary drivers for any individual woman is the first step toward addressing it. The major modifiable contributors include:
Sleep deprivation. This is almost certainly the largest single contributor to cognitive symptoms in perimenopausal women who are experiencing hot flashes. Research has found that sleep disruption alone, even in the absence of hormonal changes, produces the word-finding difficulties, memory lapses, and processing slowness that women attribute to 'brain fog.' Deep sleep is when the brain consolidates memories formed during the day and clears metabolic waste products through the glymphatic system. Fragmented sleep — even if its total hours appear adequate — impairs both functions.
Anxiety and depression. Both increase during perimenopause and both independently impair cognitive function. Anxiety produces a narrowing of attentional resources; the cognitive system is preoccupied with monitoring for threat, leaving fewer resources for word retrieval, working memory, and sustained concentration. Depression impairs executive function, motivation, and information processing speed. When anxiety or depression is treated, cognitive symptoms frequently improve alongside mood.
Thyroid-Stimulating Hormone (TSH) level is a basic and important part of any clinical evaluation of perimenopause cognitive symptoms. A diagnosis of 'perimenopause brain fog' should not precede thyroid evaluation.
Cortisol and chronic stress. The perimenopausal HPA axis is more reactive; chronic stress produces elevated cortisol that, over time, impairs hippocampal function. The midlife convergence of hormonal transition, peak caregiving demands, and career pressure creates a neurological environment in which chronic stress amplifies the direct cognitive effects of hormonal change.
What Can Actually Help
Addressing perimenopause brain fog means addressing its contributors; not just waiting for the transition to end.
Treat the sleep disruption. CBT-I (Cognitive Behavioral Therapy for Insomnia) is the most effective long-term treatment for insomnia and has documented downstream improvements in cognitive function. Addressing the vasomotor symptoms that fragment sleep, through hormonal or non-hormonal means , is a cognitive intervention as much as a comfort one.
Evaluate for thyroid, iron, and other reversible contributors. A basic medical workup including TSH, ferritin (iron is essential for neurotransmitter synthesis and cognitive function), and comprehensive metabolic panel can identify treatable contributors that are frequently overlooked.
Aerobic exercise. This is one of the most robustly supported cognitive interventions across the lifespan. Regular aerobic exercise increases BDNF, supports hippocampal neurogenesis, and has been shown to directly moderate cognitive symptoms during the menopause transition.
Psychological support for the fear. For women whose cognitive symptoms are accompanied by significant anxiety about dementia, particularly those with family history, the fear itself deserves direct attention. Cognitive anxiety about memory lapses can become its own source of cognitive impairment: hypervigilance for forgetting, performance anxiety during word retrieval, and rumination all reduce the available cognitive resources for the tasks at hand. A therapist who understands the perimenopause context can help disentangle genuine symptom from anxious amplification and work with the specific fear of dementia in ways that are both honest and grounding.
When to Seek a Neurological Evaluation
For most perimenopausal women, the cognitive changes described in this article do not require neurological evaluation. But certain signs warrant a conversation with a neurologist, ideally to establish a cognitive baseline:
A significant family history of early-onset Alzheimer's or other dementia (onset before age 60) in a first-degree relative. Cognitive symptoms that are progressively worsening over months, not fluctuating. Symptoms beyond word-finding — getting lost in familiar places, significant difficulty with complex tasks previously managed easily, changes in personality or judgment. Any concern about rapid cognitive change that does not fit the fluctuating pattern of perimenopausal brain fog. In these cases, a neuropsychological evaluation establishes a baseline and provides objective data; which, for most women, is deeply reassuring rather than alarming.
About the Author
Dr. Julie Rashkis is a licensed psychologist and Menopause Society Certified Practitioner with over 20 years of clinical experience. She specializes in the psychological dimensions of perimenopause and menopause, including the fear and distress that cognitive changes produce during the transition. She is the founder of Therapy for Midlife, a virtual practice licensed in California and Wisconsin, seeing clients across all PSYPACT-participating states.
www.therapyformidlife.com | Book a free consultation
References
1. Joffe, H., et al. (2022). Brain fog in menopause: A health-care professional's guide for decision-making and counseling on cognition. Menopause, 29(9). Tandfonline.
2. Epperson, C. N., et al. (2011). Perimenopause and cognition. Obstetrics and Gynecology Clinics of North America, 38(3), 519-535. PMC3185244.
3. Greendale, G. A., et al. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72(21), 1850-1857. [SWAN]
4. Henderson, V. W. (2010). Action of estrogens in the aging brain: Dementia and cognitive aging. Biochimica et Biophysica Acta, 1800(10), 1077-1083.
5. Wharton, W., et al. (2013). Neurobiological underpinnings of the estrogen-mood relationship. Current Psychiatry Reviews, 8(3), 247-256.
6. Gleason, C. E., et al. (2015). Effects of hormone therapy on cognition and mood in recently postmenopausal women: Findings from the KEEPS. PLOS Medicine, 12(6).
7. Shumaker, S. A., et al. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA, 289(20), 2651-2662. [WHIMS]
8. Bove, R., et al. (2014). Surgical oophorectomy and the timing of estrogen treatment in relation to cognitive decline. Neurology, 83(7), 605-611.
9. Alvarez, J. A., et al. (2024). Cognitive problems in perimenopause: A review of recent evidence. PMC10842974. 10. Kilpi, F., et al. (2020). Changes to word-finding, verbal memory, and processing speed at perimenopause. Menopause. 11. UT Physicians / Mosquera, A. B. (2025). Understanding brain fog and menopause. utphysicians.com.
